ATE178650T1 - D-enzymzusammensetzungen und verfahren zu deren verwendung - Google Patents

D-enzymzusammensetzungen und verfahren zu deren verwendung

Info

Publication number
ATE178650T1
ATE178650T1 AT93916447T AT93916447T ATE178650T1 AT E178650 T1 ATE178650 T1 AT E178650T1 AT 93916447 T AT93916447 T AT 93916447T AT 93916447 T AT93916447 T AT 93916447T AT E178650 T1 ATE178650 T1 AT E178650T1
Authority
AT
Austria
Prior art keywords
receptor
compound
contacting
modulate
amino acids
Prior art date
Application number
AT93916447T
Other languages
English (en)
Inventor
Stephen Brian Henry Kent
Saskia Charlotte Floren Milton
Raymond Cecil Delisle Milton
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25403558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE178650(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE178650T1 publication Critical patent/ATE178650T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
AT93916447T 1992-06-05 1993-06-07 D-enzymzusammensetzungen und verfahren zu deren verwendung ATE178650T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89481792A 1992-06-05 1992-06-05

Publications (1)

Publication Number Publication Date
ATE178650T1 true ATE178650T1 (de) 1999-04-15

Family

ID=25403558

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93916447T ATE178650T1 (de) 1992-06-05 1993-06-07 D-enzymzusammensetzungen und verfahren zu deren verwendung
AT98108855T ATE366744T1 (de) 1992-06-05 1993-06-07 Verknüpftes d-protein und verfahren zur identifizierung von rezeptor aktivität modulierenden verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98108855T ATE366744T1 (de) 1992-06-05 1993-06-07 Verknüpftes d-protein und verfahren zur identifizierung von rezeptor aktivität modulierenden verbindungen

Country Status (9)

Country Link
US (5) US6548279B1 (de)
EP (2) EP0647266B1 (de)
JP (2) JPH08501207A (de)
AT (2) ATE178650T1 (de)
AU (2) AU678768B2 (de)
CA (1) CA2137378C (de)
DE (2) DE69334152T2 (de)
ES (1) ES2290976T3 (de)
WO (1) WO1993025667A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647266B1 (de) * 1992-06-05 1999-04-07 The Scripps Research Institute D-enzymzusammensetzungen und verfahren zu deren verwendung
US5780221A (en) * 1995-05-03 1998-07-14 Whitehead Institute For Biomedical Research Identification of enantiomeric ligands
WO1997021690A1 (en) * 1995-11-28 1997-06-19 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
AU3719500A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Recombination of insertion modified nucleic acids
BR0012694A (pt) 1999-07-22 2002-04-09 Procter & Gamble Conjugado de protease, composição de limpeza e composição de tratamento pessoal
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
MXPA02000840A (es) 1999-07-22 2002-07-30 Procter & Gamble Variantes de proteasa de subtilisina que tienen substituciones de aminoacidos en regiones de epitopes definidas.
BR0012693A (pt) 1999-07-22 2002-04-09 Procter & Gamble Variante, de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
CA2396320A1 (en) * 2000-01-11 2001-07-19 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US20030170846A1 (en) * 2000-04-24 2003-09-11 Weisgerber David John Enzyme variants having one or more D-amino acid substitutions
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
US7588575B2 (en) * 2003-10-21 2009-09-15 Innovative Spinal Technologies Extension for use with stabilization systems for internal structures
WO2010014830A2 (en) * 2008-07-30 2010-02-04 Cosmix Therapeutics Llc Peptide therapeutics that bind vegf and methods of use thereof
US20120129715A1 (en) 2010-11-12 2012-05-24 Sidhu Sachdev S Gb1 peptidic libraries and methods of screening the same
US9309291B2 (en) 2011-12-02 2016-04-12 Reflexion Pharmaceuticals, Inc. Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
DK2814514T3 (en) 2012-02-16 2017-12-18 Atyr Pharma Inc Histidyl tRNA synthetases for the treatment of autoimmune and inflammatory diseases
US9238676B2 (en) 2012-05-17 2016-01-19 Ra Pharmaceuticals, Inc. Peptide and peptidomimetic inhibitors
AU2014229549B2 (en) 2013-03-14 2018-11-01 The Governing Council Of The University Of Toronto Scaffolded peptidic libraries and methods of making and screening the same
AU2016260274A1 (en) 2015-05-11 2017-10-12 Shiseido Company, Ltd. Chiral analysis method and chiral analysis system for bound-type amino acid

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790240A (fr) 1971-10-19 1973-02-15 Sumitomo Chemical Co Procede de preparation de l'acide mixte (+)-cis, (+)-trans- chrysanthemique
US3963573A (en) 1975-03-03 1976-06-15 The Procter & Gamble Company Process for producing N-acyl-L-methionine
US4151198A (en) 1978-06-02 1979-04-24 American Cyanamid Company Resolution of N-acyl-DL (+)-phenylalanines
FR2443452A1 (fr) 1978-12-08 1980-07-04 Roussel Uclaf Nouveau procede de dedoublement de l'acide dl cis et dl trans chrysanthemique
US4262092A (en) 1979-05-08 1981-04-14 Ethyl Corporation Process for producing N-acyl-D-phenylalanine ester
US4290893A (en) 1979-05-08 1981-09-22 Yeda Research & Development Co. Ltd. Separation of amino acids by liquid chromatography using chiral eluants
US4423037A (en) * 1982-05-13 1983-12-27 The General Hospital Corporation Inhibitors of peptide hormone action
US4454344A (en) 1982-08-23 1984-06-12 American Cyanamid Company Method for the resolution of racemic 2-(p-difluoromethoxyphenyl)-3-methylbutyric acid
US5157019A (en) * 1986-03-18 1992-10-20 Monsanto Company Serine protease inhibitors
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US5098836A (en) * 1989-08-14 1992-03-24 Phillips Petroleum Company Deoxygenation in field preparation of polymers in aqueous solution
US5585353A (en) * 1990-02-02 1996-12-17 The Rockefeller University Antibiotic peptides containing D-amino acids
ATE176239T1 (de) * 1990-11-21 1999-02-15 Iterex Pharma Lp Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
JP3712261B2 (ja) * 1992-04-07 2005-11-02 ザ スクリップス リサーチ インスティテュート 修飾タンパク質の製造方法
EP0647266B1 (de) * 1992-06-05 1999-04-07 The Scripps Research Institute D-enzymzusammensetzungen und verfahren zu deren verwendung
US5589356A (en) * 1993-06-21 1996-12-31 Vanderbilt University Litigation of sidechain unprotected peptides via a masked glycoaldehyde ester and O,N-acyl rearrangement
WO1997035194A2 (en) * 1996-03-21 1997-09-25 President And Fellows Of Harvard College Enantiomeric screening process, and compositions therefor

Also Published As

Publication number Publication date
CA2137378A1 (en) 1993-12-23
WO1993025667A1 (en) 1993-12-23
AU678768B2 (en) 1997-06-12
US7118856B2 (en) 2006-10-10
AU3756497A (en) 1997-12-18
US7135279B2 (en) 2006-11-14
JP2004275180A (ja) 2004-10-07
EP0882737B1 (de) 2007-07-11
US6548279B1 (en) 2003-04-15
DE69334152D1 (de) 2007-08-23
AU721228B2 (en) 2000-06-29
US20030113881A1 (en) 2003-06-19
EP0882737A1 (de) 1998-12-09
DE69324362T2 (de) 1999-08-26
AU4599693A (en) 1994-01-04
EP0647266A1 (de) 1995-04-12
US20040086988A1 (en) 2004-05-06
ATE366744T1 (de) 2007-08-15
JPH08501207A (ja) 1996-02-13
ES2290976T3 (es) 2008-02-16
EP0647266B1 (de) 1999-04-07
US6040133A (en) 2000-03-21
DE69324362D1 (de) 1999-05-12
US5910437A (en) 1999-06-08
JP4312615B2 (ja) 2009-08-12
CA2137378C (en) 2008-08-05
DE69334152T2 (de) 2008-03-13

Similar Documents

Publication Publication Date Title
ATE178650T1 (de) D-enzymzusammensetzungen und verfahren zu deren verwendung
DE69212011D1 (de) Endothelin Antagoniste
NO305861B1 (no) N-acylsulfaminsyre-estere -tioestere, N-acylsulfonamider og N-sulfonyl-karbaminsyre-estere, -tioestere og farmas°ytisk preparat inneholdende disse forbindelsene
PT982398E (pt) Acidos nucleicos e suas utilizacoes no teste de beta-lactamase
ATE132156T1 (de) Latente carbamat-silizium-haftvermittler und verfahren zu deren herstellung und verwendung
EP1065203A3 (de) Heterocyclische Verbindungen als Refinoid-Rezeptorantagonisten
ATE198209T1 (de) Lipopeptide aus actinoplanes sp. mit pharmakologischer wirkung, verfahren zu ihrer herstellung und verwendung derselben
ATE255165T1 (de) Rekombinantes mersacidin und verfahren zu seiner herstellung
DE69212925T2 (de) Polymerisationsinhibitoren für Acrylsäure und Ester
DE59010189D1 (de) Aminosäurederivate mit reninhemmenden Eigenschaften, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
DK159441C (da) 11-substituerede 5,11-dihydro-6h-dibenz(b,e)azepin-6-on-derivater, laegemidler indeholdende disse forbindelser og analogifremgangsmaade til forbindelsernes fremstilling
DE69832908D1 (de) Verfahren zum Inkorporieren von Aminosäureanalogen durch Verwendung von einem hypertonischen Wachstumsmedium
ATE133330T1 (de) Syntheseöle enthaltende reinigungsmittel und verfahren zur ausführung
DE58905462D1 (de) Enzym-hemmende Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung.
DE69328900T2 (de) Verfahren zur Reinigung von Teppichen
ATE144519T1 (de) Phosphinesterhaltige n-acyl-2-aminosäureamide, verfahren zu ihrer herstellung und n-acyl-2- aminosäurenitrile als vorprodukte
ATE126236T1 (de) Protein-derivate und verfahren zu ihrer herstellung.
ATE119516T1 (de) In stellung 3 durch eine halogenierte gesättigte kette substituierte 2,2- dimethylcyclopropancarbonsäurederivate, verfahren zu deren herstellung und deren verwendung zur herstellung von pestiziden produkten.
DE69607653T2 (de) Verfahren zur carbonylierung von ungesättigten acetylenverbindungen
DE69934712D1 (de) Verfahren zur herstellung von n-neohexyl-(a)-aspartyl-l-phenylalaninmethylester aus zwischenverbindungen die imidazolidin-4-on enthalten
DE69509268D1 (de) Lungentransplantat-Konservierungsmittelmischung und Verfahren zur Lebendkonservierung von Lungentransplantaten
ATE115122T1 (de) Diphenylmethanderivate, verfahren zu deren herstellung und ihre verwendung zur verdrängung von jodthyroninen und diese bindenden proteinen.
ATE84780T1 (de) Neue di(meth)acrylate, verfahren zu deren herstellung und deren verwendung.
ATE109468T1 (de) Verbindungen zur einführung einer sh-gruppe in tyrosin.
DE3874251D1 (de) Guanidin-verbindungen, die ein tetraphenylboration enthalten, verfahren, um diese zu erhalten und verwendung dieser verbindungen in der peptidsynthese.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties